Registered number
08632991
TA Pharma Limited
Filleted Accounts
31 August 2024
TA Pharma Limited
Registered number: 08632991
Balance Sheet
as at 31 August 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 300 450
Current assets
Cash at bank and in hand 42,992 21,600
Creditors: amounts falling due within one year 4 (6,373) (6,159)
Net current assets 36,619 15,441
Total assets less current liabilities 36,919 15,891
Creditors: amounts falling due after more than one year 5 (21,827) (15,675)
Net assets 15,092 216
Capital and reserves
Called up share capital 100 100
Profit and loss account 14,992 116
Shareholders' funds 15,092 216
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mohammed Hasan Noor
Director
Approved by the board on 14 March 2025
TA Pharma Limited
Notes to the Accounts
for the year ended 31 August 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Leasehold land and buildings over the lease term
Plant and machinery 10% straight line
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 2 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 September 2023 1,500
At 31 August 2024 1,500
Depreciation
At 1 September 2023 1,050
Charge for the year 150
At 31 August 2024 1,200
Net book value
At 31 August 2024 300
At 31 August 2023 450
4 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs 6,340 5,659
Other creditors 33 500
6,373 6,159
5 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans 6,827 8,675
Other creditors 15,000 7,000
21,827 15,675
6 Other information
TA Pharma Limited is a private company limited by shares and incorporated in England. Its registered office is:
99 Osborn Road
Birmingham
B11 1TU
TA Pharma Limited 08632991 false 2023-09-01 2024-08-31 2024-08-31 VT Final Accounts April 2025 Mohammed Hasan Noor No description of principal activity 08632991 2022-09-01 2023-08-31 08632991 core:WithinOneYear 2023-08-31 08632991 core:AfterOneYear 2023-08-31 08632991 core:ShareCapital 2023-08-31 08632991 core:RetainedEarningsAccumulatedLosses 2023-08-31 08632991 2023-09-01 2024-08-31 08632991 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 08632991 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 08632991 bus:Director40 2023-09-01 2024-08-31 08632991 core:PlantMachinery 2023-09-01 2024-08-31 08632991 countries:England 2023-09-01 2024-08-31 08632991 bus:FRS102 2023-09-01 2024-08-31 08632991 bus:FilletedAccounts 2023-09-01 2024-08-31 08632991 2024-08-31 08632991 core:WithinOneYear 2024-08-31 08632991 core:AfterOneYear 2024-08-31 08632991 core:ShareCapital 2024-08-31 08632991 core:RetainedEarningsAccumulatedLosses 2024-08-31 08632991 core:PlantMachinery 2024-08-31 08632991 2023-08-31 08632991 core:PlantMachinery 2023-08-31 iso4217:GBP xbrli:pure